Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Research Applications (Reta Benefits) Reta is currently being investigated in a variety of non-clinical and preclinical models, particularly those related to metabolic health
Lazaridis, University Hospital of Basel, Switzerland Asif Mehraj, Apollo Hospital, India Updates Copyright 2024 Karimi and Kohandel Gargari
Incretins contribute to the post-prandial hypoglycemia via increased GLP-1 release potentiating insulin secretion
Comparisons drawn against semaglutide and tirzepatide are cross-trial rather than head-to-head, which limits what can properly be concluded from them
US$ 20.29
US$ 23.14
US$ 27.54
US$ 28.20
US$ 21.21
US$ 26.55
US$ 25.92
US$ 27.49
